NUPATHE INC.
DelistedCIK 1375200fmd_1REXWHGQJ4C8MBDFHBX5K92RHQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 07, 2005 to Sep 30, 2013, 19 periods
| Line item | FY2005 | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|---|---|---|---|
| Research and development | – | – | – | – | 11 | 17 | 12 | 10 |
| Selling, general and administrative | – | – | – | – | 3 | 5 | 9 | 11 |
| Total operating expenses | – | – | – | – | 14 | 22 | 22 | 21 |
| Operating income | – | – | – | – | (14) | (21) | (22) | (21) |
| Interest expense | – | – | – | – | 1 | 4 | 1 | 2 |
| Interest and investment income | – | – | – | – | 0 | 0 | 0 | 0 |
| Income before taxes | – | – | – | – | (16) | (25) | (23) | (25) |
| Income tax expense | – | – | – | – | (0) | (1) | (0) | (0) |
| Net income from continuing operations | – | – | – | – | (16) | (24) | (23) | (25) |
| Net income | (1) | (5) | (10) | (18) | (16) | (24) | (23) | (25) |
| Net income to common shareholders | – | – | – | – | (19) | (27) | (23) | (38) |